Recruitment of Depressive Patients for a Controlled Clinical Trial in a Psychiatric Practice

Attempts were made to recruit moderately depressed patients to a randomized double-blind study with a new serotonergic-noradrenergic antidepressant in a psychiatry specialist's practice. Although 216 patients consulting a psychiatrist for depression were screened, none were suitable for recruitment into the study. The most common causes of exclusion were severity of depression (n = 199, 92.1 %), concomitant treatment with other psychotropic drugs (n = 124, 57.4 %) and pre-treatment with an SSRI or MAO-inhibitor (n = 97, 44.9 %). On average, there were 3.4 criteria per patient that resulted in exclusion from the study. The difficulties in recruiting patients demonstate that psychopharmacological studies with the usual inclusion and exclusion criteria are hardly practicable in an office-based psychiatric practice. Furthermore, the question to what extent results from studies performed under restrictive inclusion and exclusion criteria are applicable to routine care must also be put.

References

• 1 Angst J, Bech P, Bruinvels J, Engel R R, Ferner U, Guelfi J D, Lingjaerde O, Müller-Oerlinghausen B, Paes de Sousa M, Paykel E, Rimon R, Rzewuska M, Saletu B, Spiegel R, Stassen H H, Stoll K D, Wiesel F A, Woggon B, Zvolsky P. Report on the fifth consensus conference: Methodology of long-term clinical trials in psychiatry.  Pharmacopsychiat. 1994;  27 101-107
• 2 Baldessarini R J. Current status of antidepressants: Clinical pharmacology and therapy.  J Clin Psychiatry. 1989;  50 117-126
• 3 Balestrieri M N, Bragagnoli N, Bellantuono C. Antidepressant drug prescribing in general practice: a 6-year study.  J Affect Disord. 1991;  21 45-55
• 4 Beardsley R S, Gardocki G J, Larson D B, Hidalgo J. Prescribing of psychotropic medication by primary care physicians and psychiatrists.  Arch Gen Psychiatry. 1988;  45 1117-1119
• 5 Bowen J, Hirsch S. Recruitment rates and factors affecting recuritment for a clinical trial of a putative anti-psychotic agent in the treatment of acute schizophrenia.  Hum Psychopharmacology. 1992;  7 337-341
• 6 Eisenberg L. Treating depression and anxiety in primary care, Closing the gap between knowledge and practice.  N Engl J Med. 1992;  326 1080-1084
• 7 Gastpar M. Studies in general practice: Interpractice differences.  Pharmacopsychiat. 1984;  17 148-151
• 8 Greil W, Ludwig-Mayerhofer W, Steller B, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf G AE, Sauer H, Tegeler J, Wetterling T. The recruitment process for a multicenter study on the long-term prophylactic treatment of affective disorders.  J Affect Disord. 1993;  28 257-265
• 9 Haberfellner E M. The treatment of depressed patients in psychiatric practice. Neuropsychiatrie in press
• 10 Hohmann A A, Larson D B, Thompson J W, Beardsley R S. Psychotropic medication prescription in U.S. ambulatory medical care.  Ann Pharmacother. 1991;  25 85-89
• 11 Jakobitsch A, Haug H J, Greger J, Osterheider M, Pach J, Sprenger R, Tegeler J, Budde G. Non-compliance as a reason for inadaequat relapse preventinon in schizophrenic patients.  Psychiat Prax. 1996;  23 236-239
• 12 Licht R W, Gouliaev G, Vestergaard P, Frydenberg M. Generalizability of results from randomised drug trials.  Br J Psychiatry. 1997;  170 264-267
• 13 Linden M. Phase IV research and drug utilization observation studies.  Pharmacopsychiat. 1997;  30 (Suppl.) 1-3
• 14 Linden M. et al. .Phase IV - Forschung - Antidepressiva in der Nervenarztpraxis. Berlin, Heidelberg, New York, London, Paris, Tokio; Springer 1988
• 15 Partonen T, Sihvo S, Lönnqvist J K. Patients excluded from an antidepressant efficacy trial.  J Clin Psychiatry. 1996;  57 572-575
• 16 Zarin D A, Pincus H A, West J C, McIntyre J S. Practice-based research in psychiatry.  Am J Psychiatry. 1997;  154 1199-1208